← FDA DRUG APPROVALS

FDA NDA · NDA200732

ZIDOVUDINE

Sponsor: PHARMOBEDIENT

APPLICATION
NDA200732
TYPE
NDA
ORIGINAL APPROVAL
2011-02-23
LATEST ACTION
2019-12-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ZIDOVUDINEDiscontinued
ZIDOVUDINE 100MG · TABLET · ORAL

Approval history

2019-12-27Labeling · Supplement 2 · standardLetterAP
2013-11-08Manufacturing (CMC) · Supplement 1 · standardAP
2011-02-23Type 5 - New Formulation or New Manufacturer · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →